ED-B fibronectin as a target for antibody-based cancer treatments

By Menrad Andreas   Menssen Hans D  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 3, 2005-06 ,pp. : 491-500

Informa Healthcare

Access to resources Recommend Favorite

Diagnostic and Therapeutic Applications of Recombinant Antibodies:Targeting the Extra-Domain B of Fibronectin, A Marker of Tumor Angiogenesis

By  

Current Pharmaceutical Design, Vol. 10, Iss. 13, 2004-05 ,pp. : 1537-1549

Bentham Science Publishers

Access to resources Recommend Favorite

Antibodies for Therapeutic Uses and the Evolution of Biotechniques

By  

Current Medicinal Chemistry, Vol. 16, Iss. 6, 2009-02 ,pp. : 753-779

Bentham Science Publishers

Access to resources Recommend Favorite

To make antibodies or not: signaling by the B-cell antigen receptor

By Gold M.R.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 7, 2002-07 ,pp. : 316-324

Elsevier

Access to resources Recommend Favorite

Probing human 1 - and 2 -adrenoceptors with domain-specific fusion protein antibodies

By Jahns R.   Siegmund C.   Jahns V.   Reilander H.   Maidhof A.   Muller-Esterl W.   Lohse M.J.   Boege F.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 115-126

Elsevier

Access to resources Recommend Favorite